RCS - RUA Life Sciences - Investor Presentation

Rua Life SciencesAnnouncement

13/12/2023 14:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231213:nRSM6846Wa&default-theme=true

RNS Number : 6846W  RUA Life Sciences PLC  13 December 2023

13 December 2023

 

RUA Life Sciences Plc

 

("RUA Life Sciences", the "Company" or the "Group")

Investor Presentation - 19 December 2023

 

RUA Life Sciences plc (AIM: RUA.L), the holding company of a group of medical
device businesses focused on the exploitation of the world leading long-term
implantable biostable polyurethane (Elast-Eon™), is pleased to announce they
will conduct an Investor Presentation which will follow the publication of the
Group's interim results for the six-month period ended 30 September 2023.

 

The event will take place at 2.00pm on Tuesday 19 December with Bill Brown
(Chairman) and Lachlan Smith (Chief Financial Officer) presenting from the
company.

The online presentation is open to all existing and potential shareholders.
Questions can be submitted during the presentation to be addressed at the end.

To register for the event, please click here
(https://www.equitydevelopment.co.uk/news-and-events/rua-investor-presentation-19december2023)
.

A recording of the presentation will be available shortly afterwards here
(https://www.equitydevelopment.co.uk/research/tag/rua-life-sciences) .

 

For more information please contact:

Equity Development
Hannah Crowe / Matt Evans

020 7065 2692

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAGPGQGPUPWGCW